|
|
||||||||
Vancouver General Hospital, Vancouver, British Columbia, Canada
Correspondence: For reprints contact: D. M. Lyster, Div. of Nuclear Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada, V5Z 1M9.
ABSTRACT
Various reducing agents have been evaluated for their potential usefulness in the preparation of 99mTc labeled radiopharmaceuticals for use in nuclear medicine. Adequate labeling of various radiopharmaceuticals was accomplished using formamidine sulfinic acid. Nitrogen-purging of solutions is not required, which is an advantage for in-house preparation. Tagging requires heating, however, so heat-labile material cannot be used. Various compounds that could not be labeled when stannous chloride was used, could be tagged with 99mTc when formamidine sulfinic acid was used as the reducing agent.
FOOTNOTES
* Presently at the University of Colorado, Denver, Colorado.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |